The domestic healthcare sector is expected to see stronger growth over the next three years supported by new drug launches, while earnings from the US generics business are likely to remain flat for most companies, according to a report by Systematix Research.
The demand outlook remains strong for the Indian textile sector because of the normalizing channel inventories at the global retailer level, likely tariff hike by US on China, rising labour costs in Vietnam, and ongoing political instability in Bangladesh.